Navigation Links
Heart drug cuts prostate cancer risk; holds potential for therapeutic use
Date:4/2/2011

ry of prostate cancer, and use of other heart drugs, the lower risk of prostate cancer among digoxin users held up, the researchers say.

Platz and Yegnasubramanian say that the next steps will be to determine the mechanism of digoxin's effect on prostate cancer cells, which will support testing digoxin or other drugs that work in the same way in clinical trials as a potential prostate cancer therapy. Digoxin alters enzymatic pathways for sodium and potassium in heart cells, and according to the researchers, may also have an effect on the same or different pathways in prostate cancer.


'/>"/>

Contact: Vanessa Wasta
wasta@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Laughter Not Only Feels Good, Its Good for the Heart
2. Study suggests a relationship between migraine headaches in children and a common heart defect
3. Risks May Rise With Need for Nursing Care After Heart Failure
4. Cost of heart drugs makes patients skip pills, putting themselves at risk
5. Conflicts of Interest Cloud Heart Treatment Guidelines: Study
6. Healthy Lifestyles Could Halve Cases of Dangerous Irregular Heartbeat
7. Dark Chocolate May Harbor Benefits for the Heart
8. Americans Exposure to Mercury From Fish Wont Harm Hearts: Study
9. Outcomes improved by longer delays between heart attacks and elective surgeries
10. Study: Infrequent Sex Can Raise Risk of Heart Attack, Death
11. Do all student athletes need heart screenings?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 2013 The Ayurvedic practitioner program will ... in the West. Program is available in Mexico via ... a healing modality practiced for over 5,000 years. In ... that health begins when an individual lives in harmony ... individual needs. Ayurveda aims to heal an individual in ...
(Date:5/18/2013)... May 18, 2013 Dr. Robert Tracey, an ... dentistry, employs his knowledge of the root causes of ... patients. With May being Better Sleep Month, Dr. Tracey points ... of chronic sleep disorder, and sleep apnea is one of ... a person will essentially stop breathing at different times while ...
(Date:5/18/2013)... Wine World Accessories, a renowned online store for ... 25% discount on Franmara Dynamo Electric Wine Bottle ... this electric corkscrew opener for $44.95 via Wine World ... store ensures delivery of their items within 1-2 business ... A spokesperson from the online store elaborates the features ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Creation's Gold ... weight loss supplement, which features unmatched potency and purity ... Gold was set up to provide the very best ... work to achieve their wellness goals. The goal is ... lead happier, healthier lives. We started by supplying only ...
(Date:5/17/2013)... 17, 2013 Allen J. Schultz, D.D.S., is ... disease treatment available to residents of San Juan Capistrano. ... diseased tissue rather than relying on a scalpel to cut ... laser that works on tightly defined wavelengths to target the ... tissue intact. , Only about one in every hundred dental ...
Breaking Medicine News(10 mins):Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:Creation's Gold Launches Potent Garcinia Cambogia Supplement for Weight Loss 2Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2
... Oct. 16 International SOS Assistance, Inc. today ... services to the Department of Defense TRICARE Overseas Program. Since ... duty service members and their families receive the highest quality ... outside the United States and Puerto Rico. , ...
... given early in pregnancy might save infants most at ... -- U.S. researchers are testing a new approach in ... while they,re still in the womb. , The new ... cells that have been treated to speed and improve ...
... , SAN ANTONIO, Oct. 16 The National Trauma ... research in the United States, announced its first Request ... potential to change medical practice and save lives. , ... or translational research to take place in 2010. "Historically, ...
... Oct. 16 Amgen (Nasdaq: AMGN ) and ... data about ENBREL being presented at the 2009 American ... from Oct. 17-21, 2009. These presentations contribute to data ... , "The clinical data being presented at ACR ...
... for discussing the latest updates, information on H1N1/Swine flu , ... invited to submit questions for inclusion in a two-part tweet chat ... 10 a.m. - noon on Twitter. , Sandro Cinti, M.D., ... and VA Ann Arbor Healthcare System, will answer questions during part ...
... The European Society of Cardiology wishes to comment on ... authorise the sale of cigarettes on the internet, to ... denies that this is the intention, the news is ... last year,s smoking ban. ESC spokesperson Professeur Ph.Gabriel ...
Cached Medicine News:Health News:International SOS Awarded TRICARE Overseas Program Contract 2Health News:Transplant May Treat Metabolic Disorders in Womb 2Health News:National Trauma Institute Announces $600,000 in Funding for Trauma Research 2Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 2Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 3Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 4Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 5Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 6Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 7Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 8Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 9Health News:ESC press statement : Cigarettes on sale on the internet 2Health News:ESC press statement : Cigarettes on sale on the internet 3
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), ... , today announced that it will release its unaudited financial ... market on Tuesday, May 28, 2013.  The Company will host ... a.m. EDT (May 28, 2013 at 8:00 p.m. China Standard ... update on recent corporate developments. To access the ...
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , LISBON, Portugal, September 11 ... Confirms Superiority of the New Intranasal Treatment,for Breakthrough Cancer Pain ... today further demonstrate the efficacy of Instanyl in,management of breakthrough ... of the European Federation of Chapters of the International,Association for ...
... , THOUSAND OAKS, Calif., Sept. 10 ... new data will be presented on the burden of osteoporosis, ... American Society for Bone and Mineral Research (ASBMR) annual meeting ... being evaluated by regulatory bodies in the United States (U.S.), ...
Cached Medicine Technology:Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 2Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 3Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
The CapSure Z Novus is an endocardial, tined, high-efficiency lead. High efficiency combined with steroid elution allows safe, low output programming....
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
Medicine Products: